首页> 美国卫生研究院文献>AAPS PharmSciTech >Polymer Percolation Threshold in HPMC Extended Release Formulation of Carbamazepine and Verapamil HCl
【2h】

Polymer Percolation Threshold in HPMC Extended Release Formulation of Carbamazepine and Verapamil HCl

机译:卡马西平和维拉帕米HCl的HPMC缓释制剂中的聚合物渗滤阈值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The principles of the percolation theory were applied to further understand and design hydroxypropyl methylcellulose (HPMC) extended release matrix tablets containing carbamazepine and verapamil HCl. This statistical theory studies disordered or chaotic systems where the components are randomly distributed in a lattice. The application of this theory to study the hydration and drug release of hydrophilic matrices allows describing the changes in hydration and drug release kinetics of swellable matrices. The aim of this work was to study and develop extended release matrix formulations for carbamazepine and verapamil HCl, containing hypromellose (HPMC, METHOCEL™ Premium K100M CR) as rate controlling polymer using the concepts of percolation theory. The knowledge of the percolation threshold of the components of the matrix formulations contributes to improve their design. First, reducing the time to market and second, avoiding to formulate in the nearby of the percolation threshold, which will result in a lower variability. Therefore these formulations will be more robust when they are prepared at industrial scale. The HPMC percolation threshold for drugs with very different water solubilities was determined and it was shown that there was no significant influence of drug solubility on the HPMC critical concentration threshold (excipient percolation threshold). This may be related to the versatility and broad functionality of the swelling hydrophilic matrices.
机译:渗流理论的原理被用于进一步理解和设计含有卡马西平和维拉帕米HCl的羟丙基甲基纤维素(HPMC)缓释基质片剂。这种统计理论研究的是无序或混沌系统,其中组件随机分布在晶格中。该理论在研究亲水性基质的水合和药物释放中的应用,可以描述可溶胀基质的水合和药物释放动力学的变化。这项工作的目的是使用渗流理论概念研究和开发卡马西平和维拉帕米HCl的缓释基质制剂,其中含有羟丙甲纤维素(HPMC,METHOCEL™Premium K100M CR)作为速率控制聚合物。基质制剂各组分的渗透阈值的知识有助于改进其设计。首先,减少上市时间,其次,避免在渗滤阈值附近制定公式,这将导致较低的可变性。因此,当以工业规模制备时,这些制剂将更坚固。确定了水溶性非常不同的药物的HPMC渗透阈值,结果表明药物溶解度对HPMC临界浓度阈值(赋形剂渗透阈值)没有显着影响。这可能与溶胀的亲水性基质的多功能性和广泛的功能性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号